Диссертация (1145983), страница 35
Текст из файла (страница 35)
Kobashi // J. Epidemiol. - 2006. - Vol. 16, № 1. - P. 1-8.177. Koçyigit, Y. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic andnormotensive pregnant women / Y. Koçyigit, Y. Atamer, A. Atamer [et al.] // GynecolEndocrinol. - 2004. - Vol. 19, № 5. - P. 267-273.178. Kohler, H. P. Plasminogen-activator inhibitor type 1 and coronary artery disease / H. P.Kohler, P.
J. Grant // N Engl J Med. - 2000. - Vol. 342, № 24. - P. 1792-1801.179.Kopriva, S. E. TLR3-induced placental miR-210 down-regulates the STAT6/interleukin-4pathway / S. E. Kopriva, V. L. Chiasson, B. M. Mitchell, P. Chatterjee // PLoS One. - 2013. Vol. 8, № 9: e67760. - 9 p.180. Kosmas, I. P. Association of Leiden mutation in factor V gene with hypertension in pregnancyand pre-eclampsia: a meta-analysis / I. P. Kosmas, A. Tatsioni, J. P.
Ioannidis // J Hypertens. 2003. - Vol. 21, № 7. - P. 1221-1228.181. Kujovich J. L. Thrombophilia and pregnancy complications / J. L. Kujovich // Am J ObstetGynecol. - 2004. - Vol. 191, № 2. - P. 412-424.182. Kupferminc, M. J. Increased frequency of genetic thrombophilia in women with complicationsof pregnancy / M. J. Kupferminc, A. Eldor, N. Steinman [et al.] // N Engl J Med.
- 1999. - Vol.340, № 1. - P. 9-13.183. Kuznetsova, T. Sodium excretion as a modulator of genetic associations with cardiovascularphenotypes in the European Projecton Genes in Hypertension / T. Kuznetsova, J. A. Staessen,E. Brand [et al.] // J Hypertens. - 2006. - Vol. 24, № 2. - P. 235-242.184.
Laasanen, J. Fibrinogen and factor VII promoter polymorphisms in women with preeclampsia/ J. Laasanen, M. Hiltunen, K. Punnonen [et al.] // Obstet Gynecol. - 2002. - Vol. 100, № 2. - P.317-320.143185.Lachmeijer, A. M. A genome-wide scan for preeclampsia in the Netherlands / A. M.Lachmeijer, R. Arngrımsson, E.
J. Bastiaans [et al.] // Eur J Hum Genet. - 2001. - Vol. 9, № 10.- P. 758-764.186. Lachmeijer, A. M. Concordance for pre-eclampsia in monozygous twins / A. M. Lachmeijer, J.G. Aarnoudse, L. P. ten Kate [et al.] // Br J Obstet Gynaecol. - 1998. - Vol. 105, № 22. - P.1315-1317.187. Laivuori, H. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnishfamilies / H.
Laivuori, P. Lahermo, V. Ollikainen [et al.] // Am J Hum Genet. - 2003. - Vol. 72,№ 1. - P. 168-177.188. Lam, K. K. Glycodelin-A as a modulator of trophoblast invasion / K. K. Lam, P. C. Chiu, M.K. Chung [et al.] // Hum Reprod. - 2009. - Vol. 24, № 9. - P. 2093-2103.189. Landau, R. No association of the Asp298 variant of the endothelial nitric oxide synthase genewith preeclampsia / R. Landau, H.
G. Xie, V. Dishy [et al.] // Am J Hypertens. - 2004. - Vol. 17,№ 5 Pt 1. - P. 391-394.190. Langmead, B. Ultrafast and memory-efficient alignment of short DNA sequences to the humangenome / B. Langmead, C. Trapnell, M. Pop, S. L. Salzberg // Genome Biol. - 2009. - Vol. 10,№ 3. - P. R25.1- R25.10.191. Lau, J. Quantitative synthesis in systematic reviews / J. Lau, J. P. Ioannidis, C. H. Schmid //Ann Intern Med. - 1997.
- Vol. 127, № 9. - P. 820-826.192. Lee, D. C. miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast celllines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia andsmall-for-gestational-age pregnancies / D. C. Lee, R. Romero, J. S. Kim [et al.] // Am J Pathol. 2011. - Vol. 179, № 2. - P. 590-602.193. Li, F. miR-98 suppresses melanoma metastasis through a negative feedback loop with its targetgene IL-6 / F. Li, X. J. Li, L. Qiao [et al.] // Exp Mol Med. - 2014.
- Vol. 46. - P. e116.1e116.9.194. Li, H. Maternal plasma miRNAs expression in preeclamptic pregnancies / H. Li, Q. Ge, L.Guo, Z. Lu // Biomed Res Int. - 2013. - Vol. 2013. Article ID 970265. - 9 p.195.Li, Y. Y. Bradykinin β2 receptor -58T/C gene polymorphism and essential hypertension: Ameta-analysis / Y. Y. Li, H. Zhang, J. Xu [et al.] // PLoS One. - 2012. - Vol. 7, № 8: e43068. - 6p.196.
Lie, R. T. Fetal and maternal contributions to risk of pre-eclampsia: population based study /R. T. Lie, S. Rasmussen, H. Brunborg [et al.] // BMJ. - 1998. - Vol. 316, № 7141. - P. 13431347.144197. Lim, J. H. Genetic polymorphism of catechol-O-methyltransferase and cytochrome P450c17αin preeclampsia / J. H. Lim, S. Y. Kim, do J. Kim [et al.] // Pharmacogenet Genomics. - 2010. Vol. 20, № 10. - P. 605-610.198.
Lim, L. P. Microarray analysis shows that some microRNAs downregulate large numbers oftarget mRNAs / L. P. Lim, N. C. Lau, P. Garrett-Engele [et al.] // Nature. - 2005. - Vol. 433, №7027. - P. 769-773.199. Lin, J. Genetic thrombophilias and preeclampsia: a meta-analysis / J. Lin, P. August // ObstetGynecol.
- 2005. - Vol. 105, № 1. - P. 182–192.200.Lin, R. Angiotensinogen gene M235T and T174M polymorphisms and susceptibility of preeclampsia: a meta-analysis / R. Lin, Y. Lei, Z. Yuan [et al.] // Ann Hum Genet. - 2012. - Vol.76, № 5. - P. 377-386.201. Liu, C. J.
miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIFpathway in head and neck carcinoma / C. J. Liu, M. M. Tsai, P. S. Hung [et al.] // Cancer Res. 2010. - Vol. 70, № 4. - P. 1635-1644.202. Livingston, J. C. Maternal and fetal inherited thrombophilias are not related to thedevelopment of severe preeclampsia / J. C. Livingston, J. R. Barton, V. Park [et al.] // Am JObstet Gynecol. - 2001. - Vol. 185, № 1.
- P. 153-157.203. Lowe, S. A. Guidelines for the management of hypertensive disorders of pregnancy 2008 / S.A. Lowe, M. A. Brown, G. A. Dekker // Aust N Z J Obstet Gynaecol. - 2009. - Vol. 49, № 3. P. 242-246.204. Lu, Y. Multiple genetic variants along candidate pathways influence plasma high-densitylipoprotein cholesterol concentrations / Y. Lu, M. E. Dollé, S.
Imholz [et al.] // J Lipid Res. 2008. - Vol. 49, № 12. - P. 2582-2589.205. Luo, R. MicroRNA-210 contributes to preeclampsia by downregulating potassium channelmodulatory factor 1 / R. Luo, X. Shao, P. Xu [et al.] // Hypertension. - 2014. - Vol. 64, № 4. P. 839-845.206.
Maeno, T. The 807T allele in alpha2 integrin is protective against atherosclerotic arterial wallthickening and the occurrence of plaque in patients with type 2 diabetes / T. Maeno, H.Koyama, H. Tahara [et al.] // Diabetes. - 2002. - Vol. 51, № 5. - P. 1523-1528.207. Magnin, P.Vascular heredity and pregnancy toxemia.
Study of 222 cases of pregnancy toxemia[Abstract] // P. Magnin, R. Gaja, D. Jacquot, B. Claveyrolas // Presse Med. - 1971. - Vol. 79, №6. - P. 219-222.208. Magnussen, E. B. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia:population based cohort study / E. B. Magnussen, L. J. Vatten, T. I.
Lund-Nilsen [et al.] // BMJ.- 2007. - Vol. 335, № 7627: 978. - 9 p.145209. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads / M.Martin // EMBnet J. - 2011. - Vol. 17, № 1. - P. 10-12.210.Maruyama, A. Association study between the human Renin gene and preeclampsia / A.Maruyama, T. Nakayama, K. Furuya [et al.] // Hypertens Pregnancy. - 2005. - Vol. 24, № 1. - P.39-48.211. Mayor-Lynn, K. Expression profile of microRNAs and mRNAs in human placentas frompregnancies complicated by preeclampsia and preterm labor / K.
Mayor-Lynn, T.Toloubeydokhti, A. C. Cruz, N. Chegini // Reprod Sci. - 2011. - Vol. 18, № 1. - P. 45-56.212. Medica, I. Genetic polymorphisms in vasoactive genes and preeclampsia: a metaanalysis / I.Medica, A. Kastrin, B. Peterlin // Eur J Obstet Gynecol Reprod Biol. - 2007. - Vol. 131, № 2.
P. 115-126.213. Mello, G. Thrombophilia is significantly associated with severe preeclampsia: results of alarge-scale, case-controlled study / G. Mello, E. Parretti, L. Marozio [et al.] // Hypertension. 2005. - Vol. 46, № 6. - P. 1270-1274.214. Milne, F. The pre-eclampsia community guideline (PRECOG): how to screen for and detectonset of preeclampsia in the community / F. Milne, C. Redman, J. Walker [et al.] // BMJ. 2005. - Vol. 330, № 7491.
- P. 576–580.215. Miura, K. Identification of pregnancy-associated microRNAs in maternal plasma / K. Miura,S. Miura, K. Yamasaki [et al.] // Clin Chem. - 2010. - Vol. 56, № 11. - P. 1767-1771.216. Morales-Prieto, D. M. Elsevier trophoblast research award lecture: origin, evolution and futureof placenta miRNAs / D. M.
Morales-Prieto, S. Ospina-Prieto, A. Schmidt [et al.] // Placenta. 2014. - Vol. 35 (Suppl). - P. S39-S45.217. Morales-Prieto, D. M. Pregnancy-associated miRNA-clusters / D. M. Morales-Prieto, S.Ospina-Prieto, W. Chaiwangyen [et al.] // J Reprod Immunol. - 2013. - Vol.
97, № 1. - P. 51-61.218. Morgan L., Functional and genetic studies of the angiotensin II type 1 receptor in preeclamptic and normotensive pregnant women / L. Morgan, S. Crawshaw, P. N. Baker [et al.] // JHypertens. - 1997. - Vol. 15, № 12 Pt 1. - P. 1389-1396.219. Morgan, J. A. Association of plasminogen activator inhibitor-type 1 (-675 4G/5G)polymorphism with pre-eclampsia: systematic review / J. A. Morgan, S. Bombell, W.
McGuire// PLoS One. - 2013. - Vol. 8, № 2: e56907. - 9 p.220. Morgan, L. Distortion of maternal-fetal angiotensin II type 1 receptor allele transmission inpreeclampsia / L. Morgan, S. Crawshaw, P. N. Baker [et al.] // N. J Med Genet. - 1998. - Vol.35, № 8. - P. 632–636.221. Morrison, E. R. Prothrombotic genotypes are not associated with pre-eclampsia and gestationalhypertension: results from a large population-based study and systematic review / E. R.146Morrison, Z.
H. Miedzybrodzka, D. M. Campbell [et al.] // Thromb. Haemost. - 2002. - Vol. 87,№ 5. - P. 777-778.222.Moses, E. K. A genome scan in families from Australia and New Zealand confirms thepresence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2 / E.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
